Random effects in drug dissolution

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 3-4, 2010, Pages 430-439

  Cupera, Jakub ^a,b   Lansky, Petr ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Dissolution; Maximum likelihood estimate; Monte Carlo method; Stochastic differential equation; Wiener process

Indexed keywords

ARTICLE; DRUG SOLUBILITY; PRIORITY JOURNAL; PROBABILITY; STOCHASTIC MODEL;

MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS; SOLUTIONS; STOCHASTIC PROCESSES; TIME FACTORS;

EID: 77957268773     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.07.011     Document Type: Article

References (30)

1. Berry M.R., Likar M.D. Statistical assessment of dissolution and drug release profile similarity using a model-dependent approach. Journal of Pharmaceutical and Biomedical Analysis 2007, 45:194-200.
2. Casault S., Slater G. Systematic characterization of drug release profiles from finite-sized hydrogels. Physica A: Statistical Mechanics and its Applications 2008, 387:5387-5402.
3. Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001, 13:123-133.
4. Dokoumetzidis A., Macheras P. A population growth model of dissolution. Pharmaceutical Research 1997, 14:1122-1126.
5. Dokoumetzidis A., Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. International Journal of Pharmaceutics 2006, 321:1-11.
6. Dokoumetzidis A., Papadopoulou V., Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharmaceutical Research 2006, 23:256-261.
7. Dokoumetzidis A., Papadopoulou V., Valsami G., Macheras P. Development of a reaction-limited model of disolution: application to official dissolution tests experiments. International Journal of Pharmaceutics 2008, 255:114-125.
8. Elkoshi Z. On the variability of dissolution data. Pharmaceutical Research 1997, 10:1355-1362.
9. Garbacza G., Golkea B., Wedemeyer R.S., Axell M., Soderlindb E., Abrahamsson B., Weitschies W. Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses. European Journal of Pharmaceutical Sciences 2009, 38:147-155.
10. Garthwaite P.H., Jollife I.Y., Jones B. Statistical Inference 2002, Oxford University Press, Oxford. 2nd edition.
11. Hixson A.W., Crowell J. Dependence of reaction velocity upon surface and agitation. Industrial and Engineering Chemistry Research 1931, 23:923-931.
12. Kalampokis A., Argyrakis P., Macheras P. Heterogenous tube model for the study of small intestinal transit flow. Pharmaceutical Research 1999, 16:87-91.
13. Kalampokis A., Argyrakis P., Macheras P. A heterogenous tube model of intestinal drug absorption based on probabilistic concepts. Pharmaceutical Research 1999, 16:1764-1769.
14. Kosmidis K., Macheras P. Monte Carlo simulations of drug release from matrices with periodic layers of high and low diffusivity. International Journal of Pharmaceutics 2008, 354:111-116.
15. Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmacy and Pharmacology 1972, 24:979-981.
16. Lansky P., Lanska V., Weiss M. A stochastic differential equation model for drug dissolution and its parameters. Journal of Controlled Release 2004, 100:267-274.
17. Lansky P., Weiss M. Does the dose solubility ratio affect the mean dissolution time of drugs?. Pharmaceutical Research 2001, 16:1470-1478.
18. Lansky P., Weiss M. Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. Journal of Pharmaceutical Sciences 2003, 8:1632-1647.
19. Lee J.C., Chen D.T., Hung H.N., Chen J.J. Analysis of drug dissolution data. Statistics in Medicine 1999, 18:799-814.
20. Macheras P., Iliadis A. Modeling In Biopharmaceutics, Pharmacokinetics And Pharmacodynamics 2006, Springer-Verlag, Berlin.
21. Noyes A.A., Whitney W.R. Uber die auflosungsgeschwindigkeit von festen stoffen in ihren eigenen losungen. Zeitschrift fur Physikalische Chemie 1897, 13:689-692.
22. Øksendal B. Stochastic Differential Equations: An Introduction with Applications 1998, Springer, Berlin.
23. Papadopoulou V., Kosmidis K., Vlachou M., Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. International Journal of Pharmaceutics 2006, 309:44-50.
24. Pereira L.M. Fractal pharmacokinetics. Computational and Mathematical Methods in Medicine 2010, 11:161-184.
25. Polli J.E., Rekhi G.S., Augsburger L.L., Shah V.P. Methods to compare dissolution profiles and a rationale for wide dissolution specification for metoprolol tablets. Journal of Pharmaceutical Sciences 1997, 6:690-700.
26. Qureshi S.A., Shabnam J. Cause of high variability in drug dissolution testing and its impact on setting tolerances. European Journal of Pharmaceutical Sciences 2001, 12:271-276.
27. Sathe P.M., Tsong Y., Shah V.P. In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharmaceutical Research 1996, 13:1799-1803.
28. Schreiner T., Schaefer U., Loth H. Immediate drug release from solid oral dosage forms. Journal of Pharmaceutical Sciences 2005, 94:120-133.
29. Tuckwell H.C., Lansky P. On the simulation of biological diffusion process. Computers in Biology and Medicine 1997, 27:1-7.
30. Valsami G., Macheras P. Determination of fractal reaction dimension in dissolution studies. European Journal of Pharmaceutical Sciences 1995, 3:163-169.